AesRx to Present Phase 1 Data on Anti-Sickling Agent Aes-103 at American Society of Hematology
11/27/2012 12:27:11 PM
More...
|
AesRx Anti-Sickling Drug Aes-103 Enters Phase 1/2a Clinical Trial at National Institutes of Health (NIH)
5/14/2012 11:00:50 AM
More...
|
AesRx Begins Clinical Trial of AES-103 for Sickle Cell Disease
12/6/2011 9:19:33 AM
More...
|
AesRx Announces Collaboration With National Institutes of Health (NIH) to Develop Aes-103 for Sickle Cell Disease
11/17/2010 2:24:13 PM
More...
|
Professor Henry Louis Gates, Jr., Joins AesRx Strategic Advisory Board
6/1/2010 2:25:53 PM
More...
|
AesRx Appoints Jordan, CMO of Sickle Cell Disease Association of America, to Clinical Advisory Board
2/25/2010 11:33:24 AM
More...
|
Former Idera Pharmaceuticals, Inc. (IDRA) CEO at Helm of AesRx, New Startup With Sickle Cell Drug
1/5/2010 7:25:35 AM
More...
|